SCHEMBL25098367

SCHEMBL25098367

OC[C@H]1O[C@@H](n2cnc3c(Cl)ncnc32)C(F)C1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 3/20 0.64
▸ ADORA2A P29274 2/20 0.64
▸ ADORA1 P30542 2/20 0.64
▸ PDE2A O00408 1/20 0.64
▸ ADRA1A P35348 1/20 0.64
▸ PDE4D Q08499 1/20 0.64
▸ PDE3A Q14432 1/20 0.64
▸ SLC29A1 Q99808 10/20 0.59
▸ STAT6 P42226 2/20 0.59
▸ DPP4 P27487 1/20 0.59
▸ MEN1 O00255 1/20 0.59
▸ SLC28A1 O00337 1/20 0.59
▸ MAP3K7 O43318 1/20 0.59
▸ SLC28A2 O43868 1/20 0.59
▸ GAPDH P04406 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ ADORA2B P29275 1/20 0.59
▸ PI4KA P42356 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9850177 1.00 ADORA3 (0.64) ADORA3ADORA2AADORA1PDE2AADRA1A
SCHEMBL10490915 0.91 SLC29A1 (0.59) ADORA3ADORA2AADORA1SLC29A1STAT6
SCHEMBL67126 0.89 SLC29A1 (0.73) ADORA3ADORA2AADORA1SLC29A1STAT6
SCHEMBL91050 0.89 SLC29A1 (0.73) ADORA3ADORA2AADORA1SLC29A1STAT6
SCHEMBL10340725 0.89 SLC29A1 (0.73) ADORA3ADORA2AADORA1SLC29A1STAT6
SCHEMBL18873532 0.89 SLC29A1 (0.73) ADORA3ADORA2AADORA1SLC29A1STAT6
SCHEMBL272122 0.89 SLC29A1 (0.73) ADORA3ADORA2AADORA1SLC29A1STAT6
SCHEMBL3164068 0.89 SLC29A1 (0.73) ADORA3ADORA2AADORA1SLC29A1STAT6
SCHEMBL21139429 0.89 SLC29A1 (0.73) ADORA3ADORA2AADORA1SLC29A1STAT6
SCHEMBL1858029 0.89 SLC29A1 (0.73) ADORA3ADORA2AADORA1SLC29A1STAT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022155418-A9 MODIFIED OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-03-09 — — WO disclosed
Send feedback